This research study is currently not recruiting patients.
See other Lung Neoplasm Research Studies
A Pilot Study for Blood Based Biomarkers for Patients with Lung Cancer Receiving Radiation Therapy
Study Overview
The purpose of this study is to collect blood and tissue samples from patients with lung cancer before, during and after radiation therapy in order to identify potential biomarkers that might help us in the future to develop a blood or urine test that can be used to predict cancer reoccurrence and radiation therapy side effects for each individual patient.
Study Description
The purpose of this study is to collect blood and tissue samples from patients with lung cancer before, during and after radiation therapy in order to identify potential biomarkers that might help us in the future to develop a blood or urine test that can be used to predict cancer reoccurrence and radiation therapy side effects for each individual patient.
Research Study Identifier: TX6385
ClinicalTrials.gov Identifier: NCT1606191988 (IUSCC-0580)
Principal Investigator:
Tim Lautenschlaeger, MD
Not Recruiting